Skip to main content
LITTLE GREEN PHARMA LTD logo

LITTLE GREEN PHARMA LTD — Investor Relations & Filings

Ticker · LGP ISIN · AU0000074924 ASX Manufacturing
Open in API
Filings indexed 454 across all filing types
Latest filing 2021-06-20 Capital/Financing Update
Country AU Australia
Listing ASX LGP

About LITTLE GREEN PHARMA LTD

https://www.littlegreenpharma.com/

Little Green Pharma Ltd is a vertically integrated medicinal cannabis company focused on the cultivation, production, and distribution of pharmaceutical-grade cannabis medicines. The company operates advanced cultivation and manufacturing facilities, producing a diverse range of products including oils and dried flower. Adhering to Good Manufacturing Practice (GMP) standards, it ensures product consistency and safety across its entire supply chain, from genetics and breeding to final delivery. Little Green Pharma serves both domestic and international markets, maintaining a significant presence in Europe, including Germany and the United Kingdom. The company is committed to advancing clinical research and development to support the therapeutic use of cannabis for various medical conditions, focusing on patient-centric care and high-quality delivery systems.

Recent filings

Filing Released Lang Actions
Trading Halt 2 pages 286.8KB
Capital/Financing Update Classification · 95% confidence The document is a market announcement from Little Green Pharma Ltd regarding a request for a trading halt on its securities pending announcements about a proposed acquisition and associated capital raising. It references ASX Listing Rule 17.1 and states the halt is to manage continuous disclosure obligations until the announcements are made. The document does not contain any financial data, report content, or detailed disclosures but is an announcement about a trading halt related to upcoming announcements. This fits the category of Capital/Financing Update (CAP) because it concerns a capital raising and acquisition announcement pending, and the trading halt is directly related to these financing activities. The document length is short and it is clearly an announcement, not a full report or transcript.
2021-06-20 English
Notice of General Meeting 40 pages 679.8KB
Proxy Solicitation & Information Statement Classification · 100% confidence The document is titled 'NOTICE OF EXTRAORDINARY GENERAL MEETING' and includes detailed information about the meeting date, location, voting procedures, resolutions to be considered, and proxy instructions. It also contains an Explanatory Memorandum that provides additional information to shareholders about the matters to be voted on at the meeting. The content focuses on the announcement and details of the meeting itself rather than the results or outcomes of the meeting or any financial data. There is no indication that this document is a report of voting results or a management report, nor does it contain financial statements or earnings data. The document is a formal notice to shareholders about an upcoming extraordinary general meeting, which fits the category of Proxy Solicitation & Information Statement (PSI) as it provides information to shareholders to solicit their votes for the meeting resolutions.
2021-06-16 English
Letter to Shareholders regarding General Meeting 2 pages 250.9KB
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a notice for an Extraordinary General Meeting (EGM) of Little Green Pharma Ltd, detailing the meeting date, location, virtual participation instructions, proxy voting procedures, and related shareholder information. It does not contain financial statements, audit information, or management discussion. It is not an announcement of voting results but a notice inviting shareholders to participate and vote. The document is a meeting notice rather than the meeting materials or results. Therefore, it fits the category of Proxy Solicitation & Information Statement (PSI), which includes materials sent to shareholders to provide information and request votes for meetings, including EGMs.
2021-06-16 English
Exclusive distribution partner - leading Polish pharma group 3 pages 406.9KB
Capital/Financing Update Classification · 95% confidence The document is an ASX announcement dated 17 June 2021 about Little Green Pharma signing an exclusive distribution agreement with a Polish pharmaceutical group. It details the terms of the agreement, the parties involved, market context, and company background. There are no financial statements, quarterly or annual results, or regulatory certifications. The content is focused on a business partnership and distribution agreement, which is a capital or financing update related to the company's sales and market expansion strategy. It is not an earnings release, annual report, or any other financial report type. Therefore, the most appropriate classification is Capital/Financing Update (CAP). The document length (7896 characters) supports it being a full announcement rather than a brief notice or report publication announcement.
2021-06-16 English
Update to Sales and Distribution in Australia and Germany 3 pages 371.6KB
Capital/Financing Update Classification · 90% confidence The document is an ASX announcement dated 15 June 2021 from Little Green Pharma Ltd providing updates on the company's sales and distribution for the quarter ending 30 June 2021 (Q4 FY2021). It discusses clarifications to medicinal cannabis wholesaling rules by the Therapeutic Goods Administration (TGA) and updates on a purchase order delivery from a German wholesaler, DEMECAN. The content focuses on operational updates, regulatory clarifications, and sales order status rather than presenting comprehensive financial statements or detailed financial performance analysis. The document length is 6616 characters, which is relatively short and consistent with an announcement rather than a full financial report. There is no indication that this is a full quarterly or annual report, nor is it a transcript, audit report, or other specialized filing. The nature of the content aligns best with a Capital/Financing Update (CAP) as it relates to sales, distribution, and order updates impacting revenue recognition and operational cash flow. Therefore, the most appropriate classification is Capital/Financing Update (CAP).
2021-06-14 English
Becoming a substantial holder - Tiga Trading Pty Ltd 4 pages 177.5KB
Major Shareholding Notification Classification · 100% confidence The document is a Form 603 Notice of Initial Substantial Holder filed under section 671B of the Corporations Act 2001 (Cth). It details the substantial shareholding of TIGA Trading Pty Ltd in Little Green Pharma Limited, including voting power, relevant interests, acquisition dates, and associates. This type of filing is a notification of changes in significant share ownership levels, which corresponds to the category of Major Shareholding Notification. The document is not a financial report, earnings release, or management report, but a regulatory disclosure about shareholding thresholds being crossed.
2021-06-09 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.